Session Track · PDDS 2027 · Track 08

Pharmacovigilance and Drug Safety at PDDS 2027

Part of the PDDS 2027 scientific program · Olympia Hotel, Events & Spa, Valencia, Spain · September 13–15, 2027

About the Pharmacovigilance and Drug Safety Session

Pharmacovigilance is also called as drug safety, it is a pharmacological science that is related to the detection, collection, assessment, monitoring, and prevention of adverse effects with the therapeutic products. The term "Pharmacovigilance" is originated from Pharmakon (Greek for drug) and Vigilare (Latin for to stay watch).

It usually focuses on adverse drug reactions, or ADRs, that are defined as any response to a drug that is toxic and undesirable, including lack of efficacy. Therapeutic errors like high-dose, misuse, and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are significant.

Featured Speakers — Pharmacovigilance and Drug Safety 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Pharmacovigilance and Drug Safety Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at PDDS 2027

Why Attend the Pharmacovigilance and Drug Safety Conference 2027

Present Your Research

Oral and poster slots for original Pharmacovigilance and Drug Safety work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Learn from Keynotes

Plenary lectures from leading voices shaping Pharmacovigilance and Drug Safety research and practice.

Hybrid Flexibility

Attend in person in Valencia or join virtually — same program, same certificate.

Join PDDS 2027 for the Pharmacovigilance and Drug Safety track

Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.

Pharmacovigilance and Drug Safety Conference 2027 — FAQs

What is the Pharmacovigilance and Drug Safety track at PDDS 2027?

The Pharmacovigilance and Drug Safety track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Pharmacovigilance and Drug Safety. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Pharmacovigilance and Drug Safety sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Pharmacovigilance and Drug Safety are all welcome — whether presenting or attending.

Can I present my research in the Pharmacovigilance and Drug Safety track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.

Is virtual attendance available for Pharmacovigilance and Drug Safety sessions?

Yes. PDDS 2027 is a hybrid conference — attend the Pharmacovigilance and Drug Safety track in person in Valencia or join live online, with on-demand access afterward.

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.